Michael Bookman insider trades: Immuneering (IMRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | IMRX | ↑ Buy | 1,020 | $6.83 | $7K | Direct | Oct 2, 2025 (1d) |
| May 17, 2022 | IMRX | ↑ Buy | 1,000 | $4.88 | $5K | Direct | May 18, 2022 (1d) |
| Aug 3, 2021 | IMRX | ↑ Buy | 1,402 | $15.00 | $21K | Direct | Aug 4, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMRX insiders
Open-market trades in the last 12 months
About Michael Bookman's insider trades
Michael Bookman is Chief Legal Officer, Secretary at Immuneering (IMRX). Since Aug 3, 2021, Michael has reported 3 open-market purchases worth $33K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.